Carbetapentane / chlorpheniramine / phenylephrine Pregnancy and Breastfeeding Warnings
Brand names: Carbaphen 12, Exratuss, Tannate-12, Tanni-Hist 12 RF, Tannic-12, Tussi-12 (old formulation), XiraTuss
Carbetapentane / chlorpheniramine / phenylephrine Pregnancy Warnings
Carbetapentane/chlorpheniramine/phenylephrine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Carbetapentane/chlorpheniramine/phenylephrine is only recommended for use during pregnancy when benefit outweigh risk.
Carbetapentane / chlorpheniramine / phenylephrine Breastfeeding Warnings
There are no data on the excretion of carbetapentane/chlorpheniramine/phenylephrine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
See also
References for pregnancy information
- (2002) "Product Information. XiraTuss (carbetapentane/chlorpheniramine/phenylephrine)." Cypress Pharmaceutical Inc
References for breastfeeding information
- (2002) "Product Information. XiraTuss (carbetapentane/chlorpheniramine/phenylephrine)." Cypress Pharmaceutical Inc
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
